{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T03:47:19Z","timestamp":1784692039724,"version":"3.55.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T00:00:00Z","timestamp":1746230400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005616","name":"Allergan Foundation","doi-asserted-by":"publisher","award":["IIT-2017-10136"],"award-info":[{"award-number":["IIT-2017-10136"]}],"id":[{"id":"10.13039\/100005616","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.clineuro.2025.108949","type":"journal-article","created":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T01:23:17Z","timestamp":1746321797000},"page":"108949","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Vestibular migraine: Onabotulinum toxin effectivity, prospective-randomized study"],"prefix":"10.1016","volume":"254","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0215-0614","authenticated-orcid":false,"given":"Reyhan","family":"Surmeli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Surmeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayse Destina","family":"Yalcin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayse Asli","family":"Sahin Yilmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tulay","family":"Erden Habesoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gozde","family":"Gunay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clineuro.2025.108949_bib1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3988\/jcn.2007.3.3.121","article-title":"Migraine associated vertigo","volume":"3","author":"Cha","year":"2007","journal-title":"J. Clin. Neurol."},{"key":"10.1016\/j.clineuro.2025.108949_bib2","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1177\/0333102413485658","article-title":"The international classification of headache disorders, 3rd edition (beta version)","volume":"33","author":"Headache Classification Committee of the International Headache Society (IHS)","year":"2013","journal-title":"Cephalalgia"},{"key":"10.1016\/j.clineuro.2025.108949_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/0333102417738202","article-title":"The international classification of headache disorders, 3rd edition","volume":"38","author":"Headache Classification Committee of the International Headache Society (IHS)","year":"2018","journal-title":"Cephalalgia"},{"key":"10.1016\/j.clineuro.2025.108949_bib4","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3389\/fneur.2016.00166","article-title":"Vestibular Function Tests for Vestibular Migraine: Clinical Implication of Video Head Impulse and Caloric Tests","volume":"7","author":"Kang","year":"2016","journal-title":"Front. Neurol."},{"key":"10.1016\/j.clineuro.2025.108949_bib5","doi-asserted-by":"crossref","first-page":"326","DOI":"10.5152\/iao.2016.2338","article-title":"Correlation between cVEMP and ABR for the evaluation of vestibular migraine","volume":"12","author":"S\u00fcrmeli","year":"2016","journal-title":"J. Int. Adv. Otol."},{"key":"10.1016\/j.clineuro.2025.108949_bib6","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3389\/fneur.2017.00258","article-title":"The video head impulse test","volume":"8","author":"Halmagyi","year":"2017","journal-title":"Front. Neurol."},{"key":"10.1016\/j.clineuro.2025.108949_bib7","article-title":"Pharmacological agents for the prevention of vestibular migraine","volume":"6","author":"Maldonado Fern\u00e1ndez","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.clineuro.2025.108949_bib8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10072-015-2195-0","article-title":"Rationale for use of onabotulinum toxin A (BOTOX) in chronic migraine","volume":"36","author":"Barbanti","year":"2015","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.clineuro.2025.108949_bib9","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/nur.4770130405","article-title":"A critical review of visual analogue scales in the measurement of clinical phenomena","volume":"13","author":"Wewers","year":"1990","journal-title":"Res. Nurs. Health"},{"key":"10.1016\/j.clineuro.2025.108949_bib10","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1468-2982.1999.019002107.x","article-title":"Reliability of the migraine disability assessment score in a population-based sample of headache sufferers","volume":"19","author":"Stewart","year":"1999","journal-title":"Cephalalgia"},{"key":"10.1016\/j.clineuro.2025.108949_bib11","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/j.1526-4610.2004.04146.x","article-title":"Validity and reliability of the Turkish Migraine Disability Assessment (MIDAS) questionnaire","volume":"44","author":"Erta\u015f","year":"2004","journal-title":"Headache"},{"key":"10.1016\/j.clineuro.2025.108949_bib12","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.anl.2012.11.002","article-title":"Detection of isolated covert saccades with the video head impulse test in peripheral vestibular disorders","volume":"40","author":"Bl\u00f6dow","year":"2013","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.clineuro.2025.108949_bib13","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jns.2013.05.003","article-title":"OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baseline","volume":"331","author":"Silberstein","year":"2013","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.clineuro.2025.108949_bib14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/nyas.12488","article-title":"Development of onabotulinumtoxinA for chronic migraine","volume":"1329","author":"Whitcup","year":"2014","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1016\/j.clineuro.2025.108949_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1572","article-title":"Altered structure of the vestibular cortex in patients with vestibular migraine","volume":"10","author":"Zhe","year":"2020","journal-title":"Brain Behav."},{"key":"10.1016\/j.clineuro.2025.108949_bib16","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1749-6632.2009.03852.x","article-title":"Vertigo as a symptom of migraine","volume":"1164","author":"Lempert","year":"2009","journal-title":"Ann. N. Y Acad. Sci."},{"key":"10.1016\/j.clineuro.2025.108949_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005537-199801001-00001","article-title":"Medical management of migraine-related dizziness and vertigo","volume":"108","author":"Johnson","year":"1998","journal-title":"Laryngoscope"},{"key":"10.1016\/j.clineuro.2025.108949_bib18","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.bjorl.2016.04.022","article-title":"Prophylactic treatment of vestibular migraine","volume":"83","author":"Salmito","year":"2017","journal-title":"Braz. J. Otorhinolaryngol."},{"key":"10.1016\/j.clineuro.2025.108949_bib19","first-page":"2304","article-title":"Treatment of vestibular migraine: a systematic review and meta-analysis","author":"Byun","year":"2020","journal-title":"Laryngoscope 130"},{"key":"10.1016\/j.clineuro.2025.108949_bib20","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s00415-009-0111-3","article-title":"\"Vestibular migraine\": effects of prophylactic therapy with various drugs. A retrospective study","volume":"256","author":"Baier","year":"2009","journal-title":"J. Neurol."},{"key":"10.1016\/j.clineuro.2025.108949_bib21","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/wnf.0b013e31803bb3ee","article-title":"Effects of valproate on vestibular symptoms and electronystagmographic findings in migraine patients","volume":"30","author":"Celiker","year":"2007","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.clineuro.2025.108949_bib22","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1056\/NEJMra010917","article-title":"Migraine--current understanding and treatment","volume":"346","author":"Goadsby","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clineuro.2025.108949_bib23","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3389\/fneur.2017.00524","article-title":"The efficacy of venlafaxine, flunarizine, and valproic acid in the prophylaxis of vestibular migraine","volume":"8","author":"Liu","year":"2017","journal-title":"Front. Neurol."},{"key":"10.1016\/j.clineuro.2025.108949_bib24","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/lary.25445","article-title":"Propranolol and venlafaxine for vestibular migraine prophylaxis: a randomized controlled trial","volume":"126","author":"Salviz","year":"2016","journal-title":"Laryngoscope"},{"key":"10.1016\/j.clineuro.2025.108949_bib25","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/03655230701596491","article-title":"Migraine-associated vertigo: clinical characteristics of Japanese patients and effect of lomerizine, a calcium channel antagonist","volume":"559","author":"Iwasaki","year":"2007","journal-title":"Acta Otolaryngol."},{"key":"10.1016\/j.clineuro.2025.108949_bib26","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1007\/s10072-015-2270-6","article-title":"Fixed combination of cinnarizine and dimenhydrinate in the prophylactic therapy of vestibular migraine: an observational study","volume":"36","author":"Teggi","year":"2015","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.clineuro.2025.108949_bib27","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1046\/j.1526-4610.43.7s.4.x","article-title":"Synaptic transmission: inhibition of neurotransmitter release by botulinum toxins","volume":"43","author":"Dolly","year":"2003","journal-title":"Headache"},{"key":"10.1016\/j.clineuro.2025.108949_bib28","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/01.iio.0000167167.10402.74","article-title":"Pharmacology and immunology of botulinum neurotoxins","volume":"45","author":"Aoki","year":"2005","journal-title":"Int. Ophthalmol. Clin."},{"key":"10.1016\/j.clineuro.2025.108949_bib29","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.3390\/toxins7093818","article-title":"Botulinum toxin type A as a therapeutic agent against headache and related disorders","volume":"7","author":"Luvisetto","year":"2015","journal-title":"Toxins"},{"key":"10.1016\/j.clineuro.2025.108949_bib30","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1177\/0333102414561873","article-title":"J. Pascual, Long-term experience with onabotulinumtoxinA in the treatment of chronic migraine: What happens after one year?","volume":"35","author":"Cernuda-Morollon","year":"2015","journal-title":"Cephalalgia"},{"key":"10.1016\/j.clineuro.2025.108949_bib31","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10072-013-1381-1","article-title":"Onabotulinum toxin A for treatment of chronic migraine with medication overuse","volume":"34","author":"Grazzi","year":"2013","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.clineuro.2025.108949_bib32","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1129-2377-15-54","article-title":"Prospective analysis of the use of OnabotulinumtoxinA (BOTOX) in the treatment of chronic migraine; real-life data in 254 patients from Hull, UK","volume":"15","author":"Khalil","year":"2014","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.clineuro.2025.108949_bib33","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.3389\/fneur.2019.01009","article-title":"The role of onabotulinum toxin type A in the management of chronic non-migraine headaches","volume":"10","author":"Jia","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.clineuro.2025.108949_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.955158","article-title":"A preliminary trial of botulinum toxin type A in patients with vestibular migraine: a longitudinal fMRI study","volume":"13","author":"Oh","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.clineuro.2025.108949_bib35","series-title":"Calcitonin gene-related peptide receptor. StatPearls [Internet]","author":"Rashid","year":"2024"},{"key":"10.1016\/j.clineuro.2025.108949_bib36","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1111\/ene.14828","article-title":"Partial and nonresponders to onabotulinumtoxinA can benefit from anti-CGRP monoclonal antibodies preventive treatment: a real-world evidence study","volume":"28","author":"Alpuente","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.clineuro.2025.108949_bib37","article-title":"Calcitonin gene-related peptide monoclonal antibody Versus Botulinum Toxin for the Preventive treatment of chronic migraine: evidence from Indirect Treatment comparison","volume":"12","author":"Lu","year":"2021","journal-title":"Front. Pharm."},{"key":"10.1016\/j.clineuro.2025.108949_bib38","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s10194-024-01721-6","article-title":"Real-world effectiveness of Anti-CGRP monoclonal antibodies compared to OnabotulinumtoxinA (RAMO) in chronic migraine: a retrospective, observational, multicenter, cohort study","volume":"25","author":"Grazzi","year":"2024","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.clineuro.2025.108949_bib39","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1007\/s00415-009-5132-4","article-title":"Vestibular-evoked myogenic potentials in vestibular migraine","volume":"256","author":"Baier","year":"2009","journal-title":"J. Neurol."},{"key":"10.1016\/j.clineuro.2025.108949_bib40","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.clinph.2012.09.027","article-title":"Cervical vestibular evoked myogenic potentials in primary headache disorders","volume":"124","author":"Kandemir","year":"2013","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.clineuro.2025.108949_bib41","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/nyas.12645","article-title":"Vestibular migraine","volume":"1343","author":"Furman","year":"2015","journal-title":"Ann. N. Y Acad. Sci."},{"key":"10.1016\/j.clineuro.2025.108949_bib42","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/S1474-4422(13)70107-8","article-title":"Vestibular migraine: clinical aspects and pathophysiology","volume":"12","author":"Furman","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.clineuro.2025.108949_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1332973","article-title":"Prophylactic treatments for vestibular migraine: a systematic review and network meta-analysis of randomized clinical trials","volume":"14","author":"Chu","year":"2023","journal-title":"Front. Pharm."}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030384672500232X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030384672500232X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T20:32:35Z","timestamp":1762288355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030384672500232X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":43,"alternative-id":["S030384672500232X"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2025.108949","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vestibular migraine: Onabotulinum toxin effectivity, prospective-randomized study","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2025.108949","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"108949"}}